Based on Stoke Therapeutics’ preliminary estimates, which scaled annual incidence to prevalence using country-specific live birth rates over the past 85 years and adjusted for Dravet-specific ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback